Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial.

Thumbnail
Name:
Publisher version
Author
Abhishek, Abhishek
Boyton, Rosemary J
Peckham, Nicholas
McKnight, Áine
Coates, Laura C
Bluett, James
Barber, Vicki
Cureton, Lucy
Francis, Anne
Appelbe, Duncan
Affiliation
9. Abhishek A, Boyton RJ, Peckham N, McKnight Á, Coates LC, Bluett J, et al
Publication date
2022-06-27

Metadata
Show full item record
Abstract
no Abstract
Citation
Abhishek A, Boyton RJ, Peckham N, McKnight Á, Coates LC, Bluett J, et al
Type
Article
Handle
http://hdl.handle.net/20.500.14200/4391
Additional Links
Doi:10.1016/S2214-2600(22)00186-2
DOI
10.1016/S2213-2600(22)00186-2
PMID
35772416
Journal
The Lancet Respiratory Medicine
Publisher
Elsevier
Collections